XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

Stocks tumble as data sparks slowdown worries



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Stocks tumble as data sparks slowdown worries</title></head><body>

US manufacturing gauge drops to eight-month low

Arm Holdings down after tepid Q2 revenue forecast

Eli Lilly up as weight-loss drug cut heart failure risk in trial

Indexes down: Dow 1.57%, S&P 1.76%, Nasdaq 2.76%

Updated at 2:18 p.m. ET/1818 GMT

By Chuck Mikolajczak

NEW YORK, Aug 1 (Reuters) - U.S. stocks tumbled on Thursday as early gains evaporated, after a round of economic data spurred concerns the economy may be slowing faster than anticipated while the Federal Reserve maintains a restrictive monetary policy.

Equities initially opened higher, buoyed in part by gains in Meta PlatformsMETA.O after its quarterly resultstopped expectations and the Facebook parent issued an upbeat outlook for the third quarter. Its shares were last up 4.37% and $495.55.

Stocks turned lower, however, after data showed a measure of manufacturing activity from the Institute for Supply Management (ISM) dropped to an eight-month low in July at 46.8, signifying contraction.

"The ISM is really what started the ball rolling today and then selling causes more selling," said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder in New York.

"We're still in earnings season and there will be positive surprises that will probably drive the market higher and there may be negative surprises as well... but if you get something negative like ISM, it causes profit-taking."

The Dow Jones Industrial Average .DJI fell 641.99 points, or 1.57%, to 40,200.80, the S&P 500 .SPXlost 97.64 points, or 1.76%, to 5,424.66 and the Nasdaq Composite .IXIC lost 485.21 points, or 2.76%, to 17,114.19.

Other data showed the number of Americans filing new applications for unemployment benefits increased to an 11-month high last week, suggesting some softening in the labor market, although seasonal factors also played a role.

Both the S&P 500 and Nasdaq registered their biggest daily percentage gains since February in the prior session, boosted by a rally in chip shares after the Fed kept rates steady, as expected.

Defensive sectors such as utilities.SPLRCU and real estate.SPLRCR led gains, as geopolitical concerns boosted the dollar and pulled Treasury yields lower.

Declines in megacap names such as AppleAAPL.O and AmazonAMZN.O ahead of their quarterly results due after the closing bell weighed heavily on the tech .SPLRCT and consumer discretionary .SPLRCD indexes, which were among the worst performing of the 11 major S&P sectors.

The small-cap Russell 2000 .RUT slumped over 3% and was on track for its biggest daily percentage drop since Feb 13. Small caps have been among the first stocks to benefit as investors rotate out of more expensive stocks.

Nvidia NVDA.O slumped 8.21% in a broader chip stocks rout sparked byArm Holdings' ARM.O conservative revenue forecast and Qualcomm QCOM.O flagging a revenue hit from the impact of trade curbs, dragging those stocks down 17.01% and 9.74%, respectively.

Moderna MRNA.Oslumped 20.73% after cutting its2024 sales forecast for COVID-19 and respiratory syncytial virus vaccines by up to 25%.

Eli Lilly LLY.Nrose 3% aftertrial results showed weight-loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure.

Declining issues outnumbered advancers by a 2.22-to-1 ratio on the NYSE, and by a 3.58-to-1 ration on the Nasdaq.

The S&P 500 posted 50 new 52-week highs and seven new lows, while the Nasdaq Composite recorded 61 new highs and 144 new lows.


US unemployment claims https://reut.rs/3yqdYFJ

Q2 earnings growth on track for most S&P 500 sectors Q2 earnings growth on track for most S&P 500 sectors https://reut.rs/3Sv5ZOz


Reporting by Chuck Mikolajczak
Editing by Marguerita Choy

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques